SCHEMBL10208486

SCHEMBL10208486

CC(=O)c1cn(C[C@@H]2CCCN2)cc(OCc2ccccc2)c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
SGMS2 Q8NHU3 2/20 0.40
KCNH2 Q12809 1/20 0.40
MCHR1 Q99705 1/20 0.40
KDM2B Q8NHM5 1/20 0.40
BRD4 O60885 2/20 0.38
LTA4H P09960 3/20 0.38
GHSR Q92847 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10208482 0.75 KLK7 (0.48) MEN1KMT2AGHSR
SCHEMBL10208487 0.74 MET (0.48) MEN1ALDH1A1KMT2AMAPTSMN1; SMN2
SCHEMBL10266566 0.72 KDM2B (0.36) ALDH1A1SMN1; SMN2L3MBTL1KDM2BCHRNB4
SCHEMBL10265397 0.70 KDM2B (0.46) KCNH2KDM2B
SCHEMBL10265774 0.69 LMNA (0.36) ALDH1A1SMN1; SMN2L3MBTL1KDM2B
SCHEMBL10208483 0.68 MAPT (0.55) MEN1ALDH1A1KMT2AMAPTCYP2C9
SCHEMBL9038558 0.65 GLA (0.60) HTR2CHTR2BALDH1A1KMT2AL3MBTL1
SCHEMBL10208753 0.65 MAPT (0.53) MEN1KMT2AMAPTCYP2C9CYP2C19
SCHEMBL4741712 0.64 ALDH1A1 (0.52) HTR2CHTR2BMEN1ALDH1A1KMT2A
SCHEMBL8246719 0.64 ALDH1A1 (0.52) HTR2CHTR2BMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8835461-B2 Substituted 3-hydroxy-4-pyridone derivative SHIONOGI & CO., LTD. (JP) 2014-09-16 US disclosed
US-20120022255-A1 SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE SHIONOGI & CO., LTD. (JP) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120022255-A1 SUBSTITUTED 3-HYDROXY-4-PYRIDONE DERIVATIVE ENDOD1, CNBP, DPP4 HTR2C 1711/4885HTR2B 1962/4885MEN1 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.